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coronary surgical patients. Many centers nationally have partici-
pated in rehabilitating postoperative patients, perhaps with better
results than the authors discuss in their report. Too many studies
of postoperative patients (as well as postmyocardial infarction pa-
tients) with coronary artery disease do not adequately assess the
role of risk factor modification, particularly the use of exercise in
cardiac rehabilitation.
ELIHU YORK, MD, FACC
Hartford Hospital
Hartford. Connecticut 06115
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Reply
It is just not possible to accurately assess the impact of risk factor
modification on a consecutive series of patients who have under-
gone surgery and have been followed up for 10 postoperative years.
Not all patients in such a group will be able to submit to the
consistent long-term monitoring required to document compliance
to cardiac rehabilitation programs. The difficulty involved in study-
ing the influence of cardiac rehabilitation on long-term prognosis
is not unique to our institution. Although it may be that "many
centers nationally have participated in rehabilitating postoperative
patients," few data are available.
It is our opinion that both risk factor modification and exercise
rehabilitation are indicated in postoperative patients. Elimination
of tobacco use, dietary counseling and an exercise program are
all integral parts of our approach to the postoperative patient at
The Cleveland Clinic Foundation. However, it is important to
separate opinion and fact, and the facts are that neither risk factor
modification nor exercise rehabilitation has been documented to
influence the survival or event-free survival of postoperative patients.
BRUCE W. LYTLE, MD, FACC
The Cleveland Clinic Foundation
Department of Cardiothoracic Surgery
9500 Euclid Avenue
Cleveland. Ohio 44106
Correction
Owing to an error by the compositor, the last paragraph on
page 1160 of the article by the IMPACT Research Group
entitled "International Mexiletine and Placebo Antiar-
ryhthmic Coronary Trial: I. Report on Arrhythmia and Other
Findings" (J Am ColI Cardiol 1984;4: 1148-63) was in-
correctly printed. The correct version of the paragraph ap-
pears below.
Conclusions. IMPACT as well as other studies have
demonstrated the antiarrhythmic efficacy of mexiletine, but
the mortality findings suggest that the suppression of ven-
tricular premature complexes and arrhythmias in patients
after myocardial infarction may not result in a reduced mor-
tality rate. This is in contrast to treatment with beta-receptor
blocking agents, where an antiarrhythmic effect may be one
of the goals. IMPACT did not address the question of whether
patients with specific types of arrhythmia may benefit from
treatment that suppresses arrhythmia. The results of
IMPACT as well as other studies raise questions concerning
the hypothesis that control of arrhythmia will result in in-
creased survival for the majority of patients with myocardial
infarction.
